SunOpta Announces Third Quarter Fiscal 2021 Financial Results
SunOpta (STKL) reported Q3 2021 revenue of $198.5 million, marking a 3.6% increase, driven by a 16.0% rise in plant-based foods, which generated $114.9 million. The company experienced a loss of $3.0 million from continuing operations, an improvement from $3.9 million in Q3 2020. Adjusted EBITDA increased by 8.4% to $15.6 million. Gross margin declined to 11.8% due to supply chain challenges and rising costs. The long-term outlook remains positive for double-digit growth in plant-based revenue, despite short-term supply chain headwinds.
- 16.0% growth in plant-based foods revenue.
- Adjusted EBITDA up 8.4% to $15.6 million.
- Improved loss from continuing operations, down to $3.0 million from $3.9 million.
- Gross margin decreased to 11.8%, down 220 basis points due to supply chain issues.
- 9.7% decline in fruit-based foods revenue.
Plant-Based revenue growth of
Loss from continuing operations was
Adjusted EBITDA increased
All amounts are expressed in
Third quarter 2021 highlights:
-
Revenues of
for the third quarter of 2021 increased$198.5 million 3.6% reflecting16.0% growth in plant-based foods and beverages partially offset by a9.7% decline in fruit-based foods and beverages. -
Gross margin decreased 220 basis points to
11.8% from14.0% in the third quarter of 2020, reflecting temporary supply chain challenges and incremental depreciation expense. -
Loss from continuing operations was
compared to a loss from continuing operations of$3.0 million in the third quarter of 2020. The loss included$3.9 million of business development, facility consolidation and project costs for capacity expansion.$2.8 million -
Adjusted earnings¹ attributable to common shareholders was
or$1.1 million per diluted common share in the third quarter of 2021, compared to an adjusted loss of$0.01 ( or ($5.8) million ) per diluted common share in the third quarter of 2020.$0.06 -
Adjusted EBITDA¹ of
, or$15.6 million 7.9% of revenues for the third quarter of 2021, was up8.4% versus or$14.4 million 7.5% of revenues in the third quarter of 2020.
“Despite recent global supply chain issues, our plant-based business produced another solid quarter of growth, delivering a record setting third quarter, more than offsetting declines in our fruit-based business. Plant-based revenues were up
Third Quarter 2021 Results
Revenues of
Gross profit was
Segment operating income¹ was
Adjusted EBITDA¹ was
Loss from continuing operations attributable to common shareholders for the third quarter of 2021 was
Adjusted earnings¹ in the third quarter of 2021 was
Please refer to the discussion and table below under “Non-GAAP Measures”.
Balance Sheet and Cash Flow
As of
Conference Call
¹ See discussion of non-GAAP measures
About
Forward-Looking Statements
Certain statements included in this press release may be considered "forward-looking statements" within the meaning of the United States Private Securities Litigation Reform Act of 1995 and applicable Canadian securities legislation, which are based on information available to us on the date of this release. These forward-looking statements include, but are not limited to, our belief that investment in plant-based foods and beverages will continue to be a significant driver of revenue and margin growth, and our ability to drive further year-over-year adjusted EBITDA improvement. Generally, forward-looking statements do not relate strictly to historical or current facts and are typically accompanied by words such as “continue”, “expect”, “believe”, “anticipate”, “estimates”, “can”, “will”, “target”, "should", "would", "plans", "becoming", "intend", "confident", "may", "project", "potential", "intention", "might", "predict", “budget”, “forecast” or other similar terms and phrases intended to identify these forward-looking statements. Forward-looking statements are based on information available to the Company on the date of this release and are based on estimates and assumptions made by the Company in light of its experience and its perception of historical trends, current conditions and expected future developments including, but not limited to, the Company’s actual financial results; uninterrupted operations and service levels to our customers during the COVID-19 pandemic; current customer demand for the Company’s products and the additional anticipated demand due to the COVID-19 pandemic; general economic conditions; continued consumer interest in health and wellness; the Company’s ability to maintain product pricing levels; planned facility and operational expansions, closures and divestitures; cost rationalization and product development initiatives; alternative potential uses for the Company’s capital resources; portfolio optimization and productivity efforts; the sustainability of the Company’s sales pipeline; the Company’s expectations regarding commodity pricing, margins and hedging results; improved availability and field prices for fruit; procurement and logistics savings; freight lane cost reductions; yield and throughput enhancements; and labor cost reductions. Whether actual timing and results will agree with expectations and predictions of the Company is subject to many risks and uncertainties including, but not limited to, potential loss of suppliers and customers as well as supply chain, logistics and other disruptions resulting from or related to the COVID-19 pandemic; unexpected issues or delays with the Company’s structural improvements and automation investments; failure or inability to implement portfolio changes, process improvements, go-to-market improvements and process sustainability strategies in a timely manner; changes in the level of capital investment; local and global political and economic conditions; consumer spending patterns and changes in market trends; decreases in customer demand; delayed or unsuccessful product development efforts; potential product recalls; working capital management; availability and pricing of raw materials and supplies; potential covenant breaches under the Company’s credit facilities; and other risks described from time to time under "Risk Factors" in the Company's Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q (available at www.sec.gov). Consequently, all forward-looking statements made herein are qualified by these cautionary statements and there can be no assurance that the actual results or developments anticipated by the Company will be realized. The Company undertakes no obligation to publicly correct or update the forward-looking statements in this document, in other documents, or on its website to reflect future events or circumstances, except as may be required under applicable securities laws.
|
||||||||
Consolidated Statements of Operations |
||||||||
For the quarters and three quarters ended |
||||||||
(Unaudited) |
||||||||
(All dollar amounts expressed in thousands of |
||||||||
|
||||||||
|
Quarter ended |
|
Three quarters ended |
|
||||
|
|
|
|
|
|
|
|
|
|
$ |
|
$ |
|
$ |
|
$ |
|
|
|
|
|
|
||||
Revenues |
198,479 |
|
191,659 |
|
608,392 |
|
583,657 |
|
|
|
|
|
|
||||
Cost of goods sold |
175,123 |
|
164,821 |
|
528,711 |
|
506,387 |
|
|
|
|
|
|
||||
Gross profit |
23,356 |
|
26,838 |
|
79,681 |
|
77,270 |
|
|
|
|
|
|
||||
Selling, general and administrative expenses |
16,487 |
|
22,060 |
|
60,081 |
|
63,873 |
|
Intangible asset amortization |
2,612 |
|
2,209 |
|
7,338 |
|
6,752 |
|
Other expense, net |
1,172 |
|
1,069 |
|
7,448 |
|
789 |
|
Foreign exchange loss (gain) |
336 |
|
(543 |
) |
533 |
|
1,150 |
|
|
|
|
|
|
||||
Earnings from continuing operations before the following |
2,749 |
|
2,043 |
|
4,281 |
|
4,706 |
|
|
|
|
|
|
||||
Interest expense, net |
2,854 |
|
7,359 |
|
6,145 |
|
22,437 |
|
|
|
|
|
|
||||
Loss from continuing operations before income taxes |
(105 |
) |
(5,316 |
) |
(1,864 |
) |
(17,731 |
) |
|
|
|
|
|
||||
Income tax expense (benefit) |
2,929 |
|
(1,441 |
) |
416 |
|
(4,759 |
) |
|
|
|
|
|
||||
Loss from continuing operations |
(3,034 |
) |
(3,875 |
) |
(2,280 |
) |
(12,972 |
) |
|
|
|
|
|
||||
Earnings from discontinued operations |
- |
|
3,964 |
|
- |
|
17,429 |
|
|
|
|
|
|
||||
Net earnings (loss) |
(3,034 |
) |
89 |
|
(2,280 |
) |
4,457 |
|
|
|
|
|
|
||||
Dividends and accretion on preferred stock |
(748 |
) |
(2,844 |
) |
(3,445 |
) |
(7,473 |
) |
|
|
|
|
|
||||
Loss attributable to common shareholders |
(3,782 |
) |
(2,755 |
) |
(5,725 |
) |
(3,016 |
) |
|
|
|
|
|
||||
Basic and diluted earnings (loss) per share |
|
|
|
|
||||
From continuing operations |
(0.04 |
) |
(0.07 |
) |
(0.06 |
) |
(0.23 |
) |
From discontinued operations |
- |
|
0.04 |
|
- |
|
0.20 |
|
Basic and diluted loss per share |
(0.04 |
) |
(0.03 |
) |
(0.06 |
) |
(0.03 |
) |
|
|
|
|
|
||||
Weighted-average common shares outstanding (000s) |
|
|
|
|
||||
Basic |
107,255 |
|
89,635 |
|
103,017 |
|
88,962 |
|
Diluted |
107,255 |
|
89,635 |
|
103,017 |
|
88,962 |
|
|
||||
Consolidated Balance Sheets |
||||
As at |
||||
(Unaudited) |
||||
(All dollar amounts expressed in thousands of |
||||
|
||||
|
|
|
|
|
|
$ |
|
$ |
|
|
|
|
||
ASSETS |
|
|
||
Current assets |
|
|
||
Cash and cash equivalents |
284 |
|
251 |
|
Accounts receivable |
86,774 |
|
72,724 |
|
Inventories |
230,891 |
|
147,748 |
|
Prepaid expenses and other current assets |
16,538 |
|
21,665 |
|
Income taxes recoverable |
7,327 |
|
6,935 |
|
Total current assets |
341,814 |
|
249,323 |
|
|
|
|
||
Property, plant and equipment, net |
197,037 |
|
158,048 |
|
Operating lease right-of-use assets |
48,998 |
|
35,172 |
|
|
3,998 |
|
3,998 |
|
Intangible assets, net |
151,052 |
|
133,317 |
|
Deferred income taxes |
597 |
|
- |
|
Other assets |
5,638 |
|
5,757 |
|
|
|
|
||
Total assets |
749,134 |
|
585,615 |
|
|
|
|
||
LIABILITIES |
|
|
||
Current liabilities |
|
|
||
Accounts payable and accrued liabilities |
114,544 |
|
118,592 |
|
Income taxes payable |
5 |
|
1,431 |
|
Current portion of long-term debt |
7,734 |
|
3,478 |
|
Current portion of operating lease liabilities |
12,959 |
|
12,750 |
|
Current portion of long-term liabilities |
- |
|
200 |
|
Total current liabilities |
135,242 |
|
136,451 |
|
|
|
|
||
Long-term debt |
212,588 |
|
66,245 |
|
Operating lease liabilities |
38,090 |
|
24,582 |
|
Long-term liabilities |
1,121 |
|
- |
|
Deferred income taxes |
25,826 |
|
25,408 |
|
Total liabilities |
412,867 |
|
252,686 |
|
|
|
|
||
Series A Preferred Stock |
- |
|
87,305 |
|
Series B-1 Preferred Stock |
28,001 |
|
27,595 |
|
|
|
|
||
EQUITY |
|
|
||
|
|
|
||
Common shares |
436,219 |
|
326,545 |
|
Additional paid-in capital |
24,150 |
|
37,862 |
|
Accumulated deficit |
(153,466 |
) |
(147,741 |
) |
Accumulated other comprehensive income |
1,363 |
|
1,363 |
|
Total equity |
308,266 |
|
218,029 |
|
|
|
|
||
Total equity and liabilities |
749,134 |
|
585,615 |
|
|
||||||||
Consolidated Statements of Cash Flows |
||||||||
For the quarters and three quarters ended |
||||||||
(Unaudited) |
||||||||
(Expressed in thousands of |
||||||||
|
||||||||
|
Quarter ended |
Three quarters ended |
||||||
|
|
|
|
|
||||
|
$ |
$ |
$ |
$ |
||||
|
|
|
|
|
||||
CASH PROVIDED BY (USED IN) |
|
|
|
|
||||
|
|
|
|
|
||||
Operating activities |
|
|
|
|
||||
Net earnings (loss) |
(3,034 |
) |
89 |
|
(2,280 |
) |
4,457 |
|
Earnings from discontinued operations |
- |
|
3,964 |
|
- |
|
17,429 |
|
Loss from continuing operations |
(3,034 |
) |
(3,875 |
) |
(2,280 |
) |
(12,972 |
) |
Items not affecting cash: |
|
|
|
|
||||
Depreciation and amortization |
8,837 |
|
7,513 |
|
25,790 |
|
22,893 |
|
Amortization of debt issuance costs |
359 |
|
1,019 |
|
993 |
|
3,023 |
|
Deferred income taxes |
3,315 |
|
2,311 |
|
(179 |
) |
5,510 |
|
Stock-based compensation |
1,250 |
|
3,435 |
|
9,593 |
|
7,425 |
|
Impairment of long-lived assets |
- |
|
- |
|
2,962 |
|
- |
|
Other |
(168 |
) |
238 |
|
(504 |
) |
211 |
|
Changes in operating assets and liabilities |
(5,494 |
) |
(1,976 |
) |
(77,472 |
) |
6,734 |
|
Net cash provided by (used in) operating activities of continuing operations |
5,065 |
|
8,665 |
|
(41,097 |
) |
32,824 |
|
Net cash provided by operating activities of discontinued operations |
- |
|
11,496 |
|
- |
|
24,751 |
|
Net cash provided by (used in) operating activities |
5,065 |
|
20,161 |
|
(41,097 |
) |
57,575 |
|
|
|
|
|
|
||||
Investing activities |
|
|
|
|
||||
Additions to property, plant and equipment |
(18,386 |
) |
(11,300 |
) |
(34,989 |
) |
(26,227 |
) |
Additions to intangible assets |
- |
|
- |
|
(25,073 |
) |
- |
|
Proceeds from sale of assets |
950 |
|
- |
|
2,300 |
|
- |
|
Other |
- |
|
- |
|
- |
|
41 |
|
Net cash used in investing activities of continuing operations |
(17,436 |
) |
(11,300 |
) |
(57,762 |
) |
(26,186 |
) |
Net cash used in investing activities of discontinued operations |
- |
|
(475 |
) |
(13,380 |
) |
(1,607 |
) |
Net cash used in investing activities |
(17,436 |
) |
(11,775 |
) |
(71,142 |
) |
(27,793 |
) |
|
|
|
|
|
||||
Financing activities |
|
|
|
|
||||
Increase (decrease) under revolving credit facilities |
11,348 |
|
3,410 |
|
123,177 |
|
(26,472 |
) |
Borrowings of long-term debt |
4,739 |
|
- |
|
9,380 |
|
- |
|
Repayment of long-term debt |
(1,849 |
) |
(624 |
) |
(11,789 |
) |
(1,702 |
) |
Payment of debt issuance costs |
(181 |
) |
(3 |
) |
(2,552 |
) |
(2,491 |
) |
Proceeds from the exercise of stock options and employee share purchases |
304 |
|
864 |
|
7,494 |
|
1,435 |
|
Payment of withholding taxes on stock-based awards |
(1,576 |
) |
(1,225 |
) |
(8,313 |
) |
(2,376 |
) |
Payment of cash dividends on preferred stock |
(609 |
) |
- |
|
(4,638 |
) |
(1,700 |
) |
Payment of share issuance costs |
- |
|
- |
|
(287 |
) |
- |
|
Proceeds from issuance of preferred stock, net of issuance costs |
- |
|
- |
|
- |
|
26,804 |
|
Other |
- |
|
- |
|
- |
|
(4 |
) |
Net cash provided by (used in) financing activities of continuing operations |
12,176 |
|
2,422 |
|
112,472 |
|
(6,506 |
) |
Net cash used in financing activities of discontinued operations |
- |
|
(11,510 |
) |
(200 |
) |
(23,847 |
) |
Net cash provided by (used in) financing activities |
12,176 |
|
(9,088 |
) |
112,272 |
|
(30,353 |
) |
|
|
|
|
|
||||
Increase (decrease) in cash and cash equivalents in the period |
(195 |
) |
(702 |
) |
33 |
|
(571 |
) |
|
|
|
|
|
||||
Cash and cash equivalents of discontinued operations: |
|
|
|
|
||||
Balance at beginning of period |
- |
|
1,152 |
|
- |
|
1,370 |
|
Foreign exchange gain on cash and cash equivalents |
- |
|
15 |
|
- |
|
11 |
|
Less: balance at end of period |
- |
|
(678 |
) |
- |
|
(678 |
) |
|
|
|
|
|
||||
Cash and cash equivalent, beginning of the period |
479 |
|
473 |
|
251 |
|
128 |
|
|
|
|
|
|
||||
Cash and cash equivalents, end of the period |
284 |
|
260 |
|
284 |
|
260 |
|
|
||||||||
Segmented Information |
||||||||
For the quarters and three quarters ended |
||||||||
Unaudited |
||||||||
(Expressed in thousands of |
||||||||
|
||||||||
|
Quarter ended |
|
Three quarters ended |
|||||
|
|
|
|
|
|
|
|
|
|
$ |
|
$ |
|
$ |
|
$ |
|
Segment revenues from external customers: |
|
|
|
|
||||
|
114,870 |
|
99,038 |
|
345,680 |
|
296,985 |
|
|
83,609 |
|
92,621 |
|
262,712 |
|
286,672 |
|
Total segment revenues from external customers |
198,479 |
|
191,659 |
|
608,392 |
|
583,657 |
|
|
|
|
|
|
||||
Segment gross profit: |
|
|
|
|
||||
|
18,697 |
|
19,715 |
|
61,751 |
|
57,517 |
|
|
4,659 |
|
7,123 |
|
17,930 |
|
19,753 |
|
Total segment gross profit |
23,356 |
|
26,838 |
|
79,681 |
|
77,270 |
|
|
|
|
|
|
||||
Segment operating income (loss): |
|
|
|
|
||||
|
8,056 |
|
13,119 |
|
30,014 |
|
37,456 |
|
|
(3,517 |
) |
(1,788 |
) |
(6,858 |
) |
(8,506 |
) |
Corporate Services |
(618 |
) |
(8,219 |
) |
(11,427 |
) |
(23,455 |
) |
Total segment operating income |
3,921 |
|
3,112 |
|
11,729 |
|
5,495 |
|
|
|
|
|
|
||||
Segment gross profit percentage: |
|
|
|
|
||||
|
16.3 |
% |
19.9 |
% |
17.9 |
% |
19.4 |
% |
|
5.6 |
% |
7.7 |
% |
6.8 |
% |
6.9 |
% |
Total segment gross profit percentage |
11.8 |
% |
14.0 |
% |
13.1 |
% |
13.2 |
% |
|
|
|
|
|
||||
Segment operating income (loss) percentage: |
|
|
|
|
||||
|
7.0 |
% |
13.2 |
% |
8.7 |
% |
12.6 |
% |
|
-4.2 |
% |
-1.9 |
% |
-2.6 |
% |
-3.0 |
% |
Total segment operating income percentage |
2.0 |
% |
1.6 |
% |
1.9 |
% |
0.9 |
% |
Non-GAAP Measures
In addition to reporting financial results in accordance with
In order to evaluate its results of operations, the Company uses certain other non-GAAP measures that it believes enhance an investor’s ability to derive meaningful period-over-period comparisons and trends from the results of operations. In particular, the Company evaluates its revenues on a basis that excludes the effects of fluctuations in commodity pricing and the impacts of acquisitions and divestitures. In addition, the Company excludes specific items from its reported results that due to their nature or size, it does not expect to occur as part of its normal business on a regular basis. These items are identified in the tables below. These non-GAAP measures are presented solely to allow investors to more fully assess the Company’s results of operations and should not be considered in isolation of, or as substitutes for an analysis of the Company’s results as reported under
Adjusted Earnings/Loss
When assessing its financial performance, the Company uses an internal measure that excludes charges and gains that it believes are not reflective of normal operations. This information is provided to allow investors to make meaningful comparisons of the Company’s operating performance between periods and to view the Company’s business from the same perspective as the Company’s management. Adjusted earnings/loss and adjusted earnings/loss per diluted share should not be considered in isolation or as a substitute for performance measures calculated in accordance with
The following is a tabular presentation of adjusted earnings/loss and adjusted earnings/loss per diluted share, including a reconciliation from earnings/loss from continuing operations, which the Company believes to be the most directly comparable
|
|||||||||
|
|
|
|||||||
|
|
|
Per Share |
|
|
|
|
Per Share |
|
For the quarter ended |
$ |
|
$ |
|
|
$ |
|
$ |
|
Loss from continuing operations |
(3,034 |
) |
|
(3,875 |
) |
|
|||
Dividends and accretion on preferred stock |
(748 |
) |
|
(2,844 |
) |
|
|||
Loss from continuing operations attributable to common shareholders |
(3,782 |
) |
(0.04 |
) |
(6,719 |
) |
(0.07 |
) |
|
Adjusted for: |
|
|
|
|
|||||
Business development costs(a) |
1,782 |
|
|
- |
|
|
|||
Workforce reduction charges(b) |
499 |
|
|
- |
|
|
|||
Costs related to exit from fruit ingredient processing facility(c) |
479 |
|
|
- |
|
|
|||
Legal settlements(d) |
- |
|
|
721 |
|
|
|||
Plant expansion costs(e) |
- |
|
|
245 |
|
|
|||
Costs related to Value Creation Plan(f) |
- |
|
|
174 |
|
|
|||
Other(g) |
40 |
|
|
294 |
|
|
|||
Net income tax effect(h) |
2,121 |
|
|
(495 |
) |
|
|||
Adjusted earnings (loss) |
1,139 |
|
0.01 |
|
(5,780 |
) |
(0.06 |
) |
(a) |
Represents third-party costs associated with business development activities, including costs related to the evaluation, execution, and integration of external acquisitions and internal expansion projects, or completion of divestitures. For the third quarter of 2021, these costs reflected the transition and integration of the acquired Dream and WestSoy brands and project development activities related to our new plant-based beverage facility under construction in |
|
(b) |
For the third quarter of 2021, represents severance and related benefit charges recorded in other expense, which were related to workforce reduction actions in our frozen fruit operations to reduce overhead costs. |
|
(c) |
For the third quarter of 2021, reflects inventory and equipment relocation costs related to the exit from our fruit ingredient processing facility, which were recorded in other expense. |
|
(d) |
For the third quarter of 2020, reflects a loss of |
|
(e) |
For the third quarter of 2020, reflects start-up costs related to the expansion of our plant-based extraction capabilities, which were recorded in cost of goods sold. |
|
(f) |
For the third quarter of 2020, reflects employee retention costs of |
|
(g) |
Other includes losses on the disposal of assets, which were recorded in other expense. |
|
(h) |
Reflects the tax effect of the preceding adjustments to earnings calculated based on our estimated annual effective tax rate. |
|
|||||||||
|
|
|
|
||||||
|
|
|
Per Share |
|
|
|
Per Share |
||
For the three quarters ended |
$ |
|
$ |
|
$ |
|
$ |
||
Loss from continuing operations |
(2,280 |
) |
|
(12,972 |
) |
|
|||
Dividends and accretion on preferred stock |
(3,445 |
) |
|
(7,473 |
) |
|
|||
Loss from continuing operations attributable to common shareholders |
(5,725 |
) |
(0.06 |
) |
(20,445 |
) |
(0.23 |
) |
|
Adjusted for: |
|
|
|
|
|||||
Costs related to exit from fruit ingredient processing facility(a) |
4,602 |
|
|
- |
|
|
|||
Business development costs(b) |
3,568 |
|
|
- |
|
|
|||
Costs related to Value Creation Plan(c) |
1,432 |
|
|
1,349 |
|
|
|||
Workforce reduction charges(d) |
499 |
|
|
- |
|
|
|||
Legal settlements(e) |
163 |
|
|
721 |
|
|
|||
Plant expansion costs(f) |
- |
|
|
337 |
|
|
|||
Other(g) |
124 |
|
|
(178 |
) |
|
|||
Net income tax effect(h) |
(2,141 |
) |
|
(863 |
) |
|
|||
Adjusted earnings (loss) |
2,522 |
|
0.02 |
|
(19,079 |
) |
(0.21 |
) |
(a) |
For the first three quarters of 2021, reflects closure costs related to the exit from our fruit ingredient processing facility, including asset impairment charges of |
|
(b) |
Represents third-party costs associated with business development activities, including costs related to the evaluation, execution, and integration of external acquisitions and internal expansion projects, or completion of divestitures. For the first three quarters of 2021, these costs reflected the transition and integration of the acquired Dream and WestSoy brands and project development activities related to our new plant-based beverage facility under construction in |
|
(c) |
For the first three quarters of 2021, represents costs to complete the exit from our |
|
(d) |
For the first three quarters of 2021, represents severance and related benefit charges recorded in other expense, which were related to workforce reduction actions in our frozen fruit operations to reduce overhead costs. |
|
(e) |
For the first three quarters of 2021, reflects a |
|
(f) |
Reflects costs related to the expansion of our plant-based extraction capabilities, which were recorded in cost of goods sold. |
|
(g) |
For the first three quarters of 2021, other includes losses on the disposal of assets, which were recorded in other expense. For the first three quarters of 2020, other includes the reversal of previously accrued costs related to the withdrawal of certain consumer-packaged products in 2016, partially offset by losses on disposal of assets, which were recorded in other income/expense. |
|
(h) |
Reflects the tax effect of the preceding adjustments to earnings calculated based on our estimated annual effective tax rate. |
Segment Operating Income/Loss and Adjusted EBITDA
The Company defines segment operating income/loss as net earnings/loss before income taxes, interest expense and other income/expense items, and adjusted EBITDA as segment operating income/loss plus depreciation, amortization, non-cash stock-based compensation, and other unusual items that affect the comparability of operating performance as identified above in the determination of adjusted earnings/loss. The following is a tabular presentation of segment operating income/loss and adjusted EBITDA, including a reconciliation to earnings/loss from continuing operations, which the Company believes to be the most directly comparable
|
|
|
|
||
For the quarter ended |
$ |
|
$ |
||
Loss from continuing operations |
(3,034 |
) |
(3,875 |
) |
|
Income tax expense (benefit) |
2,929 |
|
(1,441 |
) |
|
Interest expense, net |
2,854 |
|
7,359 |
|
|
Other expense, net |
1,172 |
|
1,069 |
|
|
Total segment operating income |
3,921 |
|
3,112 |
|
|
Depreciation and amortization |
8,837 |
|
7,513 |
|
|
Stock-based compensation |
1,250 |
|
3,435 |
|
|
Business development costs(a) |
1,628 |
|
- |
|
|
Plant expansion costs(b) |
- |
|
245 |
|
|
Costs related to Value Creation Plan(c) |
- |
|
120 |
|
|
Adjusted EBITDA |
15,636 |
|
14,425 |
|
(a) |
For the third quarter of 2021, third-party business development costs reflected the transition and integration of the acquired Dream and WestSoy brands and project development activities related to our new plant-based beverage facility under construction in |
|
(b) |
For the third quarter of 2020, reflects costs related to the expansion of our plant-based extraction capabilities, which were recorded in cost of goods sold. |
|
(c) |
For the third quarter of 2020, reflects employee retention costs recorded in SG&A expenses. |
|
|
|
|
||
For the three quarters ended |
$ |
|
$ |
||
Loss from continuing operations |
(2,280 |
) |
(12,972 |
) |
|
Income tax expense (benefit) |
416 |
|
(4,759 |
) |
|
Interest expense, net |
6,145 |
|
22,437 |
|
|
Other expense, net |
7,448 |
|
789 |
|
|
Total segment operating income |
11,729 |
|
5,495 |
|
|
Depreciation and amortization |
25,790 |
|
22,893 |
|
|
Stock-based compensation(a) |
9,593 |
|
8,320 |
|
|
Business development costs(b) |
2,940 |
|
- |
|
|
Costs related to Value Creation Plan(c) |
- |
|
1,103 |
|
|
Plant expansion costs(d) |
- |
|
337 |
|
|
Adjusted EBITDA |
50,052 |
|
38,148 |
|
(a) |
For the first three quarters of 2020, stock-based compensation of |
|
(b) |
For the first three quarters of 2021, third-party business development costs reflected the transition and integration of the acquired Dream and WestSoy brands and project development activities related to our new plant-based beverage facility under construction in |
|
(c) |
Reflects professional fees of |
|
(d) |
Reflects costs related to the expansion of our plant-based extraction capabilities, which were recorded in cost of goods sold. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20211110005502/en/
ICR
646-277-1260
reed.anderson@icrinc.com
Source:
FAQ
What were SunOpta's Q3 2021 revenue results?
How did SunOpta's adjusted EBITDA perform in Q3 2021?
What is SunOpta's outlook for plant-based revenue growth?
What loss did SunOpta report for continuing operations in Q3 2021?